Tenax Therapeutics

TENXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$502.977 M

$13.44 +0.98%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$52.6M

Loss-making

Shares outstanding

37,423,917

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#207Relmada TherapeuticsRLMD$518.2M
#208EvommuneEVMN$507.1M
#209Tenax TherapeuticsTENX$503.0M
#210EvolusEOLS$501.3M
#211Aquestive TherapeuticsAQST$494.3M

Where these numbers come from

Share counts and financials for Tenax Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.